Market Closed -
Canadian Securities Exchange
09:30:00 2024-04-25 am EDT
|
5-day change
|
1st Jan Change
|
0.01
CAD
|
0.00%
|
|
+100.00%
|
+100.00%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
75.91
|
17.72
|
5.059
|
3.935
|
1.124
|
Enterprise Value (EV)
1 |
74.05
|
19.06
|
-2.487
|
-1.972
|
4.947
|
P/E ratio
|
-7.96
x
|
-1.87
x
|
-21.1
x
|
-28.1
x
|
-0.1
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
3,786,087
x
|
-
|
-
|
-
|
EV / Revenue
|
-
|
4,073,918
x
|
-
|
-
|
-
|
EV / EBITDA
|
-15,678,245
x
|
-4,926,815
x
|
612,865
x
|
-
|
-
|
EV / FCF
|
-31,426,974
x
|
-5,871,979
x
|
1,559,403
x
|
2,433,729
x
|
10,066,649
x
|
FCF Yield
|
-0%
|
-0%
|
0%
|
0%
|
0%
|
Price to Book
|
5.06
x
|
2.58
x
|
0.78
x
|
0.61
x
|
-0.25
x
|
Nbr of stocks (in thousands)
|
110,014
|
110,720
|
112,417
|
112,417
|
112,417
|
Reference price
2 |
0.6900
|
0.1600
|
0.0450
|
0.0350
|
0.0100
|
Announcement Date
|
4/30/19
|
4/29/20
|
4/30/21
|
4/29/22
|
5/1/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
|
-
|
-
|
4.679
|
-
|
-
|
-
|
EBITDA
|
-
|
-4.723
|
-3.869
|
-4.058
|
-
|
-
|
EBIT
1 |
-0.792
|
-4.983
|
-4.169
|
-4.173
|
-1.01
|
-0.6097
|
Operating Margin
|
-
|
-
|
-89.11%
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-0.8276
|
-8.862
|
-9.746
|
-1.717
|
-0.1399
|
-10.89
|
Net income
1 |
-0.8276
|
-8.862
|
-9.481
|
-0.2392
|
-0.1399
|
-10.89
|
Net margin
|
-
|
-
|
-202.62%
|
-
|
-
|
-
|
EPS
2 |
-0.0800
|
-0.0867
|
-0.0857
|
-0.002137
|
-0.001244
|
-0.0968
|
Free Cash Flow
|
-
|
-2.356
|
-3.246
|
-1.595
|
-0.8102
|
0.4914
|
FCF margin
|
-
|
-
|
-69.38%
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
6/1/18
|
4/30/19
|
4/29/20
|
4/30/21
|
4/29/22
|
5/1/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
-
|
-
|
1.35
|
-
|
-
|
3.82
|
Net Cash position
1 |
3.07
|
1.86
|
-
|
7.55
|
5.91
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-0.3481
x
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-2.36
|
-3.25
|
-1.59
|
-0.81
|
0.49
|
ROE (net income / shareholders' equity)
|
-16.9%
|
-71.5%
|
-86.5%
|
-25.6%
|
-2.16%
|
-1,085%
|
ROA (Net income/ Total Assets)
|
-
|
-24.1%
|
-17.7%
|
-19.8%
|
-5.34%
|
-6.61%
|
Assets
1 |
-
|
36.8
|
53.43
|
1.206
|
2.622
|
164.8
|
Book Value Per Share
2 |
0.5200
|
0.1400
|
0.0600
|
0.0600
|
0.0600
|
-0.0400
|
Cash Flow per Share
2 |
0.1600
|
0.0200
|
0.0100
|
0
|
0.0100
|
0
|
Capex
1 |
1.62
|
3.39
|
1.75
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
37.35%
|
-
|
-
|
-
|
Announcement Date
|
6/1/18
|
4/30/19
|
4/29/20
|
4/30/21
|
4/29/22
|
5/1/23
|
|
1st Jan change
|
Capi.
|
---|
| +100.00% | 821K | | -15.13% | 4.51B | | -9.75% | 3.15B | | +2.14% | 3.1B | | -6.82% | 2.42B | | +47.87% | 1.97B | | +0.09% | 1.65B | | -7.89% | 1.68B | | -12.97% | 1.53B | | +33.40% | 1.38B |
Alternative Medicine
|